StockData
Quanterix Corp logo

Quanterix Corp (QTRX) company profile

QTRXNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3075% below fair value
$2.86+0.02 (+0.70%)

Close on Nov 17, 2026Market cap $135.26MP/E –Yield –

About Quanterix

Laboratory Analytical Instruments, SIC 3826

Quanterix Corporation is a life sciences company that provides ultra-sensitive translational research and spatial biology instruments, consumables, and laboratory services. Its proprietary Simoa platforms enable detection of protein biomarkers at concentrations down to the femtomolar range, while its spatial biology platforms allow multi-plexed cellular-level biomarker analysis in intact tissue. In addition to instruments such as the HD-X, SR-X, SP-X, PhenoCycler, and PhenoImager, the company sells consumable assay kits, reagents, and extended service contracts. It also delivers contract research services and clinical diagnostic testing, including laboratory developed tests, through its Accelerator Laboratory. Customers include research laboratories, contract research organizations, academic institutions, and bio-pharmaceutical companies.

The company distributes its products and services worldwide, supporting diagnostic and translational research primarily across neurology, oncology, and immunology. Its commercial footprint includes an installed base of more than 2,500 instruments across global research and clinical settings. Its certified Accelerator Laboratory is located in Bedford, Massachusetts.

Summary of the business section of Quanterix's latest annual report, written by StockData.

Company profile

Company

Legal name
Quanterix Corp
Founded
2007
Headquarters
Billerica, MA
Address
900 Middlesex Turnpike 01821
Phone
(617) 301-9400
Employees
450, Dec 31, 2025
Industry
Laboratory Analytical Instruments
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
KPMG LLP, Boston, Massachusetts

Stock & identifiers

Ticker
QTRX
Exchange
Nasdaq
IPO date
Dec 7, 2017
Shares outstanding
47M, Aug 3, 2026
Public float
$239.00M, Jun 30, 2025
Filer category
Accelerated filer
SEC CIK
1503274
CUSIP
74766Q101
ISIN
US74766Q1013
FIGI
BBG0027NWC69
Share class FIGI
BBG0027NWC78
EIN
20-8957988

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Everett CunninghamPresident and CEO, Director–
Masoud TolouePresident & CEO, Director507,310
Michael Francis MillerChief Technology Officer40,634
James Edward Gute Jr.Chief Commercial Officer–
Jason F. FaesslerChief Financial Officer–
Vandana SriramChief Financial Officer31,598
Benjamin MeadowsChief Commercial Officer3,500
Daniel CharChief Legal Officer–
William P. DonnellyDirector268,765
Scott MendelDirector28,454
Ivana Magovcevic-LiebischDirector15,883
Jeffrey Thomas ElliottDirector15,345
Goldman Myla LaiDirector15,041
Paul M. MeisterDirector313,253
Alan Bruce SachsDirector70,099
Karen FlynnDirector57,212
David R. WaltDirector1,872,890
Malcolm Garret HamptonDirector70,099
Sarah E. HlavinkaDirector60,070
Martin D. MadausDirector291,541

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$5.25M$1.31M$1.40M$14$125
FY2024$6.43M$1.35M$2.62M$23$93
FY2023$5.44M$10.86M$1.61M$59$94
FY2022
EKevin Hrusovsky
$1.92M-$3.81M$1.21M$30$90
FY2022
Masoud Toloue
$2.96M$1.70M$1.21M$30$90
FY2021$4.21M$7.59M$1.50M$91$100

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsOption awardsIncentive payOtherTotalvs. prior year
Masoud Toloue
Former President and Chief Executive Officer
$670.95K$1.17M$2.73M$674.17K$5.63K$5.25M-18%
Vandana Sriram
Chief Financial Officer and Treasurer
$462.25K$427.50K$997.50K$309.23K$15.75K$2.21M-15%
William P. Donnelly
Former Executive Chair
$19.32K$80.00K$408.11K–$89.41K$596.84K–

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Dec 7, 2017
Offer price
$15.00
Securities offered
4,275,200
Gross proceeds
$64.13M
Exchange
Nasdaq
First trading day
Dec 7, 2017
First-day close
$17.47+16.5%
Lock-up ends (est.)
Jun 5, 2018

“​ ​ ​ ​ ​ ​ ​ ​ Per share Total ​ ​ ​ ​ ​ ​ ​ ​ Initial public offering price $ 15.00 $ 64,128,000 Underwriting discounts and commissions (1) $ 1.05 $ 4,488,960 Proceeds to Quanterix Corporation, before expenses $ 13.95 $ 59,639,040 ​ ​ ​ ​ ​ ​ ​ ​ (1) The underwriters will receive compensation in addition to the underwriting discount.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had 450 full-time employees, of which 151 worked in sales, sales support, field service, and marketing, 24 worked in engineering and research and development, 198 worked in manufacturing and operations and 77 worked in general and administration.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?